A Pan-Cancer Analysis of UBE2S in Tumorigenesis, Prognosis, Pathway, Immune Infiltration and Evasion, and Therapy Response from an Immune-Oncology Perspective

Figure 6

Correlation of UBE2S with immune and stromal cell infiltration across TCGA cancers. Respective scatter plot of UBE2S with immune score (a) and stromal score (b) and ESTIMATE Score (c) were adopted to characterize the overall variation tendency of immune cells, stromal cells, and tumor purity at the pan-cancer level. Four algorithms of EPIC (d), MCPCOUNTER (e), QUANTISEQ (f), and TIMER (g) were applied to evaluated specific immune and stromal subsets. The correlation of UBE2S expression with MDSC, Th1, and Th2 subsets of CD4+ T cells (h).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)